Symposia replays
Evolving evidence for long-term, prophylactic treatment of HAE patients with subcutaneous C1-INH
EAACI 2021 symposium
01 – 03 July, Krakow, Poland
Chair: Prof Marcus Maurer
The European Academy of Allergy and Clinical Immunology (EAACI) hosts the world’s largest annual congress specialising in the field of allergy and clinical immunology, which takes place at various cities across the world.
CSL Behring held symposia at the annual EAACI Congress in 2021 and 2022. The discussions focussed on new HAE treatments and the evolution of the HAE management guidelines and treatment goals, with particular focus on how the use of subcutaneous C1 inhibitor for long-term prophylaxis can contribute towards achieving disease control and normalising patients’ lives.